ClinicalTrials.govpublic full text
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
multiple myeloma and plasma cell neoplasm, stage iii multiple myeloma, refractory multiple myeloma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886408
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.